William F Doyle - Net Worth and Insider Trading

William F Doyle Net Worth

The estimated net worth of William F Doyle is at least $8 Million dollars as of 2024-04-16. William F Doyle is the Executive Chairman of NovoCure Ltd and owns about 551,176 shares of NovoCure Ltd (NVCR) stock worth over $7 Million. William F Doyle is the Director of Elanco Animal Health Inc and owns about 61,330 shares of Elanco Animal Health Inc (ELAN) stock worth over $850,647. William F Doyle is also the Director of Minerva Neurosciences Inc and owns about 3,264 shares of Minerva Neurosciences Inc (NERV) stock worth over $7,899. Details can be seen in William F Doyle's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William F Doyle has not made any transactions after 2024-03-08 and currently still holds the listed stock(s).

Transaction Summary of William F Doyle

To

William F Doyle Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William F Doyle owns 7 companies in total, including NovoCure Ltd (NVCR) , Minerva Neurosciences Inc (NERV) , and OptiNose Inc (OPTN) among others .

Click here to see the complete history of William F Doyle’s form 4 insider trades.

Insider Ownership Summary of William F Doyle

Ticker Comapny Transaction Date Type of Owner
NVCR NovoCure Ltd 2022-08-02 director & 10 percent owner
NERV Minerva Neurosciences Inc 2019-06-27 director
OPTN OptiNose Inc 2017-10-12 director & 10 percent owner
ZTS Zoetis Inc 2015-02-03 director
ELAN Elanco Animal Health Inc 2024-03-08 director
DNAC Social Capital Suvretta Holdings Corp III 2022-07-11 director
PROK ProKidney Corp 2022-07-11 director

William F Doyle Latest Holdings Summary

William F Doyle currently owns a total of 3 stocks. Among these stocks, William F Doyle owns 551,176 shares of NovoCure Ltd (NVCR) as of August 2, 2022, with a value of $7 Million and a weighting of 89.09%. William F Doyle owns 61,330 shares of Elanco Animal Health Inc (ELAN) as of March 8, 2024, with a value of $850,647 and a weighting of 10.81%. William F Doyle also owns 3,264 shares of Minerva Neurosciences Inc (NERV) as of June 27, 2019, with a value of $7,899 and a weighting of 0.1%.

Latest Holdings of William F Doyle

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVCR NovoCure Ltd 2022-08-02 551,176 12.72 7,010,959
ELAN Elanco Animal Health Inc 2024-03-08 61,330 13.87 850,647
NERV Minerva Neurosciences Inc 2019-06-27 3,264 2.42 7,899

Holding Weightings of William F Doyle


William F Doyle Form 4 Trading Tracker

According to the SEC Form 4 filings, William F Doyle has made a total of 21 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in NovoCure Ltd is the sale of 837 shares on August 2, 2022, which brought William F Doyle around $58,305.

According to the SEC Form 4 filings, William F Doyle has made a total of 1 transactions in Elanco Animal Health Inc (ELAN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Elanco Animal Health Inc is the acquisition of 15,000 shares on March 8, 2024, which cost William F Doyle around $244,500.

According to the SEC Form 4 filings, William F Doyle has made a total of 1 transactions in Minerva Neurosciences Inc (NERV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Minerva Neurosciences Inc is the acquisition of 438 shares on June 27, 2019, which cost William F Doyle around $19,250.

Insider Trading History of William F Doyle

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William F Doyle Trading Performance

GuruFocus tracks the stock performance after each of William F Doyle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William F Doyle is -2.84%. GuruFocus also compares William F Doyle's trading performance to market benchmark return within the same time period. The performance of stocks bought by William F Doyle within 3 months outperforms 2 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how William F Doyle's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of William F Doyle

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -1.51 -2.84 -21.4 -24.78 -39.82 -48.61
Relative Return to S&P 500(%) -0.84 -1.69 -26.91 -36.1 -54.03 -65.91

William F Doyle Ownership Network

Ownership Network List of William F Doyle

No Data

Ownership Network Relation of William F Doyle


William F Doyle Owned Company Details

What does NovoCure Ltd do?

Who are the key executives at NovoCure Ltd?

William F Doyle is the director & 10 percent owner of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Wilhelmus Cm Groenhuysen , President & CNS Cancers US Frank X Leonard , and Chief Commercial Officer Pritesh Shah .

NovoCure Ltd (NVCR) Insider Trades Summary

Over the past 18 months, William F Doyle made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 62,300 shares made by Frank X Leonard , a net sale of 25,323 shares made by Pritesh Shah , and a net sale of 32,769 shares made by Wilhelmus Cm Groenhuysen .

In summary, during the past 3 months, insiders sold 10,224 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 10,224 shares. During the past 18 months, 352,694 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 352,694 shares.

NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovoCure Ltd Insider Transactions

No Available Data

William F Doyle Mailing Address

Above is the net worth, insider trading, and ownership report for William F Doyle. Currently GuruFocus does not have mailing address information for William F Doyle.

Discussions on William F Doyle

No discussions yet.